Emerging Therapeutic Approaches for Psoriatic Arthritis
Philip Mease, MD, MACR
Recognizing Loss of Treatment Response in Psoriatic Arthritis
SGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
Advancing Bone Health: Key Insights from ISO 2026
Marshall Miller
Ami R. Patel
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
The Cardiovascular Dimension of Psoriatic Arthritis
Understanding Difficult-to-Treat Axial Spondyloarthritis in Real-World Practice
A Visual Guide to Cutaneous Dermatomyositis
Avery H. LaChance, MD, MPH, FAAD
Measuring What Matters in Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
Unpacking the Complexity of Psoriatic Arthritis
Lawrence H. Brent
Diagnosing Psoriatic Arthritis: A Real-World Case
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
Flavia Castelino, MD
Benjamin Korman, MD
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Ryan Quigley
Progress and Practical Limits with AI in Psoriatic Arthritis
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.